Why Magnesium Helps Torsades With a Long QT
Sustained polymorphic VT requires immediate unsynchronized shock, even when a pulse is present. Magnesium is considered for recurrences associated with a long QT; it does not replace shock and is not routine treatment for normal-QT polymorphic VT.Source
Why is magnesium used for torsades de pointes?
Torsades de pointes is polymorphic ventricular tachycardia associated with a prolonged QT interval. Delayed repolarization permits early afterdepolarizations which trigger ventricular activity. Magnesium treats recurrences in this setting even when the measured magnesium level is normal. Suppression of triggered activity is a proposed mechanism. Sustained polymorphic VT requires immediate unsynchronized shock. Magnesium addresses recurrence and does not replace that treatment.
Key takeaways
- Confirm the long-QT setting rather than treating every polymorphic VT as torsades.
- Magnesium’s use in torsades is not limited to replacing a low serum magnesium.
- Address potassium abnormalities and QT-prolonging medications alongside the rhythm.
What connects a long QT to torsades?
The QT interval reflects ventricular depolarization and repolarization. When repolarization is prolonged, an early afterdepolarization can appear before the cell has completed its recovery. These abnormal depolarizations trigger repeated ventricular beats in a susceptible heart.
Torsades describes the long-QT form of polymorphic VT. A twisting-looking rhythm alone does not establish the preceding QT interval. Review the ECG and the clinical setting, including medications and electrolyte abnormalities.
For example, recurrent brief runs after exposure to a QT-prolonging medication call for a different causal review from normal-QT polymorphic VT during ischemia. The changing QRS appearance alone does not establish the same mechanism in both situations.
Why does magnesium help even with a normal level?
Suppression of early afterdepolarizations and triggered activity is a proposed explanation for magnesium’s effects in torsades. Its therapeutic role is therefore broader than replacing a measured deficiency. A normal serum concentration does not remove this mechanism-based use.
The 2025 AHA guidance considers magnesium for recurrent polymorphic VT associated with a long QT. It does not recommend treating normal-QT polymorphic VT routinely with magnesium. The underlying rhythm and cause determine the reasoning.
What must happen before waiting for a medication effect?
Sustained polymorphic VT is treated with immediate unsynchronized shock. Synchronizing reliably to a changing polymorphic waveform is difficult. Do not delay shock to wait for magnesium or another medication.
After the immediate rhythm treatment, address factors promoting recurrence. Review QT-prolonging drugs and correct relevant electrolyte abnormalities, including potassium. The video’s unstable-or-pulseless phrasing should not imply sustained polymorphic VT with a pulse is safe to observe while waiting for magnesium.
